Viatris to pay $264M to settle EpiPen lawsuit

Viatris, a drugmaker formerly known as Mylan Pharmaceuticals, on Feb. 28 agreed to pay $264 million to settle a class-action lawsuit over EpiPen pricing, The Hill reported.